Literature DB >> 27757764

Application of GPCR Structures for Modelling of Free Fatty Acid Receptors.

Irina G Tikhonova1.   

Abstract

Five G protein-coupled receptors (GPCRs) have been identified to be activated by free fatty acids (FFA). Among them, FFA1 (GPR40) and FFA4 (GPR120) bind long-chain fatty acids, FFA2 (GPR43) and FFA3 (GPR41) bind short-chain fatty acids and GPR84 binds medium-chain fatty acids. Free fatty acid receptors have now emerged as potential targets for the treatment of diabetes, obesity and immune diseases. The recent progress in crystallography of GPCRs has now enabled the elucidation of the structure of FFA1 and provided reliable templates for homology modelling of other FFA receptors. Analysis of the crystal structure and improved homology models, along with mutagenesis data and structure activity, highlighted an unusual arginine charge-pairing interaction in FFA1-3 for receptor modulation, distinct structural features for ligand binding to FFA1 and FFA4 and an arginine of the second extracellular loop as a possible anchoring point for FFA at GPR84. Structural data will be helpful for searching novel small-molecule modulators at the FFA receptors.

Entities:  

Keywords:  Allosteric site; FFA1; FFA2; FFA3; FFA4; Free fatty acid receptors; G protein-coupled receptors; GPR84; Molecular modelling; Mutagenesis; Orthosteric site; SAR

Mesh:

Substances:

Year:  2017        PMID: 27757764     DOI: 10.1007/164_2016_52

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  11 in total

1.  Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs.

Authors:  Zdenek Dvorak; Max Klapholz; Thomas P Burris; Benjamin P Willing; Antimo Gioiello; Roberto Pellicciari; Francesco Galli; John March; Stephen J O'Keefe; R Balfour Sartor; Chang H Kim; Maayan Levy; Sridhar Mani
Journal:  Mol Pharmacol       Date:  2020-08-06       Impact factor: 4.436

2.  Discovery of an Isothiazole-Based Phenylpropanoic Acid GPR120 Agonist as a Development Candidate for Type 2 Diabetes.

Authors:  Xuqing Zhang; Chaozhong Cai; Zhihua Sui; Mark Macielag; Yuanping Wang; Wen Yan; Arthur Suckow; Hong Hua; Austin Bell; Peter Haug; Wilma Clapper; Celia Jenkinson; Joseph Gunnet; James Leonard; William V Murray
Journal:  ACS Med Chem Lett       Date:  2017-07-27       Impact factor: 4.345

3.  Butyrate Protects Against Salsolinol-Induced Toxicity in SH-SY5Y Cells: Implication for Parkinson's Disease.

Authors:  Bruk Getachew; Antonei B Csoka; Amna Bhatti; Robert L Copeland; Yousef Tizabi
Journal:  Neurotox Res       Date:  2020-06-22       Impact factor: 3.911

4.  Dihydromyricetin Protects Against Ethanol-Induced Toxicity in SH-SY5Y Cell Line: Role of GABAA Receptor.

Authors:  Bruk Getachew; Antonei B Csoka; Yousef Tizabi
Journal:  Neurotox Res       Date:  2022-04-07       Impact factor: 3.911

Review 5.  Novel Pharmacotherapies in Parkinson's Disease.

Authors:  Yousef Tizabi; Bruk Getachew; Michael Aschner
Journal:  Neurotox Res       Date:  2021-05-18       Impact factor: 3.911

6.  Three classes of ligands each bind to distinct sites on the orphan G protein-coupled receptor GPR84.

Authors:  Zobaer Al Mahmud; Laura Jenkins; Trond Ulven; Frédéric Labéguère; Romain Gosmini; Steve De Vos; Brian D Hudson; Irina G Tikhonova; Graeme Milligan
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

Review 7.  Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.

Authors:  Manuel Grundmann; Eckhard Bender; Jens Schamberger; Frank Eitner
Journal:  Int J Mol Sci       Date:  2021-02-10       Impact factor: 5.923

8.  Discovery and Characterization of Novel Antagonists of the Proinflammatory Orphan Receptor GPR84.

Authors:  Laura Jenkins; Sara Marsango; Sarah Mancini; Zobaer Al Mahmud; Angus Morrison; Stuart P McElroy; Kirstie A Bennett; Matt Barnes; Andrew B Tobin; Irina G Tikhonova; Graeme Milligan
Journal:  ACS Pharmacol Transl Sci       Date:  2021-09-07

9.  Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APPswe Alzheimer's Disease Mouse Model.

Authors:  Marta Zamarbide; Eva Martinez-Pinilla; Francisco Gil-Bea; Masashi Yanagisawa; Rafael Franco; Alberto Perez-Mediavilla
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

Review 10.  Short-Chain Fatty Acid Receptors and Cardiovascular Function.

Authors:  Anastasios Lymperopoulos; Malka S Suster; Jordana I Borges
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.